Thomas Koller
Vienna, 1090, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Malondialdehyde-specific natural IgM inhibit NETosis triggered by culprit site-derived extracellular vesicles from myocardial infarction patients.
Journal: European heart journal
Published: August 14, 2023
Comparison of five Anti-SARS-CoV-2 antibody assays across three doses of BNT162b2 reveals insufficient standardization of SARS-CoV-2 serology.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: September 29, 2022
The Comparability of Anti-Spike SARS-CoV-2 Antibody Tests is Time-Dependent: a Prospective Observational Study.
Journal: Microbiology spectrum
Published: February 24, 2022
Increasing test specificity without impairing sensitivity: lessons learned from SARS-CoV-2 serology.
Increasing test specificity without impairing sensitivity: lessons learned from SARS-CoV-2 serology.
Journal: Journal of clinical pathology
Published: January 17, 2022
Anti-inflammatory and Immunomodulatory Therapies in Atherosclerosis.
Journal: Handbook of experimental pharmacology
Published: July 12, 2021
Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: July 01, 2021
Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results.
Journal: Microbiology spectrum
Published: June 16, 2021
Serum antibody response to BNT162b2 after natural SARS-CoV-2 infection.
Journal: European journal of clinical investigation
Published: March 02, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026